According to the report, the immunology market was valued at $110.1 billion in 2023, and is estimated to reach $204.0 billion by 2033, growing at a CAGR of 6.3% from 2024 to 2033.
Increase in prevalence of chronic diseases, rise in awareness and understanding of immune-related diseases, and increase in investment in research and development are the major factors that drive the growth of the immunology market. However, stringent regulatory requirements restricts the market growth. Moreover, advancements in biotechnology and molecular biology offers remunerative opportunities for the expansion of the global immunology market.
Request Sample of the Report on – https://www.alliedmarketresearch.com/request-sample/A298165
Key Takeaways
- The immunology market share study covers 20 countries. The research includes a segment analysis of each country in terms of value for the projected period.
- More than 1, 500 product literatures, industry releases, annual reports, and other such documents of major immunology industry participants along with authentic industry journals, trade associations’ releases, and government websites have been reviewed for generating high-value industry insights.
- The study integrated high-quality data, professional opinions and analysis, and critical independent perspectives. The research approach is intended to provide a balanced view of global markets and to assist stakeholders in making educated decisions in order to achieve their most ambitious growth objectives.
Segment Highlights
By Product Type
- Diagnostic Testing Equipment
- Biomarkers
- Biopharmaceuticals
By Application
- Allergy and Hypersensitivity
- Autoimmune Disease
- Infectious Disease
- HIV and AIDS
- Others
By End User
- Hospitals and Clinics
- Pharmaceutical and Biotechnology Companies
- Diagnostic Laboratories
- Others
By Region
- North America (U.S., Canada, Mexico)
- Europe (Germany, France, UK, Italy, Spain, Rest of Europe)
- Asia-Pacific (Japan, China, India, Australia, South Korea, Rest of Asia-Pacific)
- LAMEA (Brazil, Saudi Arabia, South Africa, Rest of LAMEA)
For Purchase Related Queries/Inquiry – https://www.alliedmarketresearch.com/purchase-enquiry/A298165
North America to maintain its dominance by 2033
In North America and Europe there is a robust market for immunology due to advanced healthcare systems, rise in prevalence of chronic pain conditions, and greater accessibility to healthcare services. These regions also witness significant research and development activities, leading to the introduction of innovative pain management therapies and medications. In emerging markets such as Asia-Pacific and LAMEA the immunology market is experiencing rapid growth driven by increasing healthcare expenditure, expanding pharmaceutical industries, and rising awareness about pain management.
Key Players
- AbbVie Inc.
- Johnson & Johnson
- Pfizer Inc.
- Novartis AG
- Merck & Co., Inc.
- Bristol-Myers Squibb Company
- Amgen Inc
- Eli Lilly and Company
- Gilead Sciences, Inc.
- Sanofi
Our Market Research Solution Provides You Answer to Below Mentioned Question:
- Which are the driving factors responsible for the growth of market?
- Which are the roadblock factors of this market?
- What are the new opportunities, by which market will grow in coming years?
- What are the trends of this market?
- Which are main factors responsible for new product launch?
- How big is the global & regional market in terms of revenue, sales and production?
- How far will the market grow in forecast period in terms of revenue, sales and production?
- Which region is dominating the global market and what are the market shares of each region in the overall market in 2024?
- How will each segment grow over the forecast period and how much revenue will these segments account for in 2033?
- Which region has more opportunities?
Contact Details:
David Correa
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
